Past investments
Name Stage Role Status Link
Biogen Inc. Early public Investor Public www.biogenidec.com
Idec Pharmaceuticals Early public Investor Merged with Biogen to form Biogenidec Inc.
Centocor Inc. Early Public Investor Bought by Johnson & Johnson 1999 www.janssenbiotech.com
Chiron Inc. Early Public Investor Bought by Novartis AG in 2006 www.novartis.com
Genzyme Inc. Public Investor Acquired by Sanofi Aventis www.genzyme.com
Regeneron Early public Investor Public www.regeneron.com
Cephalon Public Investor Merged with Teva Pharmaceuticals www.cephalon.com
Amylin Early public Investor Public www.amylin.com
Gilead Sciences Early public Investor Public www.gilead.com
Medimmune Public Investor Acquired by Astra Zeneca in 2002 www.medimmune.com
Biochem Pharma Early Public Investor Acquired by Shire Plc in 2001 www.shire.com
PDLI Inc. Early public Investor Public www.pdli.com
Scios Nova Inc. Early Public Investor Acquired by Johnson & Johnson 2003 www.jnj.com
Vertex Inc. Early Public Investor Public www.vertex.com
Interneuron Pharmac. Early Public Investor Acquired by Endo Pharmaceuticals 2009 www.endo.com
OSI Pharmaceuticals (OSIP) Public Investor Bought in 2010 by Astellas Ltd
Facet Biotech (FACT) Public Investor Acquired by Abbott Laboratories Inc. in 2010
QLT Inc. Public Investor Public www.qltinc.com
Idec Pharmaceuticals Inc. Public Investor Merged with Biogen to form BiogenIdec (BIIB)
Affymax Inc. Public Investor Aquired by Glaxo Smith Kline in 1995
Aviron Inc. Public Investor Bought by Medimmune Inc. in 2001
Genentech Inc. Early public Investor Bought by Roche in 2009 www.genentech.com
Glyko Biomedical Inc. Early Stage Private Investor Acquired by Biomarin Inc. www.glyko.com
Genmab A/S (Copenhagen Stock Exchange: GEN.CO) Seed-Investment Lead-Investor Public www.genmab.com
Pyrosequencing AB (Stockholm Stock Exchange: PYROa.ST) Private Investor Public www.pyrosequencing.com
Biomarin Pharmaceuticals Inc. (NASDAQ: BMRN) Early Stage Private Investor Public www.biomarinpharm.com
Profound Pharma A/S (acquired by Maxygen Inc. (NASDAQ: MAXY)) Seed Lead-Investor Public www.maxygen.com
Immunogen Inc. Early Public Investor Public www.immunogen.com
Bavarian Nordic Research Institute (Copenhagen Stock Exchange: BAVA.CO) Private Investor Public www.bavarian-nordic.com
Karo Bio AB (Stockholm Stock Exchange: KARO.ST) Pre-IPO Investor Public www.karobio.com
M&E Biotech (now Pharmexa A/S, Copenhagen Stock Exchange: PHARMX.CO) Private Investor Public www.pharmexa.com
Neurosearch A/S (Copenhagen Stock Exchange: NEUS.CO) Private Investor Public www.neurosearch.com
Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) Seed-Investment Lead-Investor Public www.acadia-pharm.com
Pantheco A/S (now Santaris Pharma A/S) Seed-Investment Lead-Investor Private www.pantheco.com
Zymenex Seed-Investment Lead-Investor Private www.hemebiotech.com
Gyros AB Spin-out Stage Investor Private www.gyros.com
7TM Pharma A/S Seed Private Investors Private www.7tmpharma.com
Personal Chemistry AB (acquired by Pyrosequencing AB, Stockholm Stock Exchange: PYROa.ST) Private Investor Public www.personalchemistry.com
Zealand Pharma A/S) Seed-Investment Private Investor Public www.zp.dk
Fibrogen Europe Oy Private Investor Private
NS Gene A/S Spin-out Co-Lead Investor Private www.nsgene.com

The above stated investments were made by Florian Schönharting at NB Capital in investment funds advised by NB Capital or in prior tenure at BankInvest Asset Management